Literature DB >> 16163264

Stargardt-like macular dystrophy protein ELOVL4 exerts a dominant negative effect by recruiting wild-type protein into aggresomes.

Vidyullatha Vasireddy1, Camasamudram Vijayasarathy, Jibiao Huang, Xiaofei F Wang, Monica M Jablonski, Howard R Petty, Paul A Sieving, Radha Ayyagari.   

Abstract

PURPOSE: Mutations in the gene Elongation of very long-chain fatty acids-4 (ELOVL4) have been shown to be associated with autosomal dominant Stargardt-like macular dystrophy (STGD3). ELOVL4 is expressed in photoreceptors and encodes a putative transmembrane protein of 314 amino acids with an endoplasmic reticulum (ER) retention signal. A 5 bp deletion in exon 6 of ELOVL4 observed in some STGD3 patients results in the truncation of the protein and loss of the ER retention signal. To understand the disease mechanism underlying STGD3 we studied the intracellular trafficking of the wild-type and a 5 bp deletion mutant of ELOVL4.
METHODS: Wild-type and mutant ELOVL4 proteins with the N-terminal GFP/V5 tags were expressed in COS-7 cells. Expression and the intracellular localization of the wild-type and mutant proteins were characterized by immunocytochemistry and western blot analysis using tag- and organelle-specific antibodies. Interaction between the wild-type and mutant proteins was studied by two-dimensional gel electrophoresis and fluorescence resonance energy transfer (FRET) analysis.
RESULTS: The mutant ELOVL4 protein exerted a dominant negative effect when the wild-type and 5 bp deletion mutant ELOVL4 proteins were co-expressed in COS-7 cells. Immunocytochemical analysis, two-dimensional gel electrophoresis and FRET revealed that the mutant ELOVL4 interacts with the wild-type protein, forming higher molecular mass complexes that accumulate in aggresomes.
CONCLUSIONS: In the presence of mutant ELOVL4 protein, the wild-type protein was recruited into perinuclear cytoplasmic inclusions that resemble aggresomes. The interaction between the wild-type and mutant forms of ELOVL4 and the resultant alteration in the trafficking of the wild-type ELOVL4 protein suggest a mechanism for the pathogenicity observed in patients with autosomal dominant STGD3.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16163264

Source DB:  PubMed          Journal:  Mol Vis        ISSN: 1090-0535            Impact factor:   2.367


  34 in total

Review 1.  The retinal pigment epithelium in health and disease.

Authors:  J R Sparrow; D Hicks; C P Hamel
Journal:  Curr Mol Med       Date:  2010-12       Impact factor: 2.222

2.  Recruitment of the oncoprotein v-ErbA to aggresomes.

Authors:  Cornelius Bondzi; Abigail M Brunner; Michelle R Munyikwa; Crystal D Connor; Alicia N Simmons; Stephanie L Stephens; Patricia A Belt; Vincent R Roggero; Manohara S Mavinakere; Shantá D Hinton; Lizabeth A Allison
Journal:  Mol Cell Endocrinol       Date:  2010-11-12       Impact factor: 4.102

3.  Loss of functional ELOVL4 depletes very long-chain fatty acids (> or =C28) and the unique omega-O-acylceramides in skin leading to neonatal death.

Authors:  Vidyullatha Vasireddy; Yoshikazu Uchida; Norman Salem; Soo Yeon Kim; Md Nawajesh Ali Mandal; Geereddy Bhanuprakash Reddy; Ravi Bodepudi; Nathan L Alderson; Johnie C Brown; Hiroko Hama; Andrzej Dlugosz; Peter M Elias; Walter M Holleran; Radha Ayyagari
Journal:  Hum Mol Genet       Date:  2007-01-05       Impact factor: 6.150

Review 4.  Retinal very long-chain PUFAs: new insights from studies on ELOVL4 protein.

Authors:  Martin-Paul Agbaga; Md Nawajes A Mandal; Robert E Anderson
Journal:  J Lipid Res       Date:  2010-03-18       Impact factor: 5.922

5.  Haploinsufficiency is not the key mechanism of pathogenesis in a heterozygous Elovl4 knockout mouse model of STGD3 disease.

Authors:  Dorit Raz-Prag; Radha Ayyagari; Robert N Fariss; Md Nawajes A Mandal; Vidyullatha Vasireddy; Sharon Majchrzak; Andrea L Webber; Ronald A Bush; Norman Salem; Konstantin Petrukhin; Paul A Sieving
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-08       Impact factor: 4.799

6.  A missense mutation in ASRGL1 is involved in causing autosomal recessive retinal degeneration.

Authors:  Pooja Biswas; Venkata Ramana Murthy Chavali; Giulia Agnello; Everett Stone; Christina Chakarova; Jacque L Duncan; Chitra Kannabiran; Melissa Homsher; Shomi S Bhattacharya; Muhammad Asif Naeem; Adva Kimchi; Dror Sharon; Takeshi Iwata; Shaikh Riazuddin; G Bhanuprakash Reddy; J Fielding Hejtmancik; George Georgiou; S Amer Riazuddin; Radha Ayyagari
Journal:  Hum Mol Genet       Date:  2016-04-22       Impact factor: 6.150

Review 7.  The bisretinoids of retinal pigment epithelium.

Authors:  Janet R Sparrow; Emily Gregory-Roberts; Kazunori Yamamoto; Anna Blonska; Shanti Kaligotla Ghosh; Keiko Ueda; Jilin Zhou
Journal:  Prog Retin Eye Res       Date:  2011-12-22       Impact factor: 21.198

8.  Hetero-oligomeric interactions of an ELOVL4 mutant protein: implications in the molecular mechanism of Stargardt-3 macular dystrophy.

Authors:  Ayaka Okuda; Tatsuro Naganuma; Yusuke Ohno; Kensuke Abe; Maki Yamagata; Yasuyuki Igarashi; Akio Kihara
Journal:  Mol Vis       Date:  2010-11-18       Impact factor: 2.367

9.  Inner retina remodeling in a mouse model of stargardt-like macular dystrophy (STGD3).

Authors:  Sharee Kuny; Frédéric Gaillard; Silvina C Mema; Paul R Freund; Kang Zhang; Ian M Macdonald; Janet R Sparrow; Yves Sauvé
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-11-20       Impact factor: 4.799

10.  Drug delivery to posterior intraocular tissues: third Annual ARVO/Pfizer Ophthalmics Research Institute Conference.

Authors:  Henry F Edelhauser; Jeffrey H Boatright; John M Nickerson
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-08-15       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.